These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19205281)

  • 1. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses.
    Compalati E; Penagos M; Tarantini F; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):22-8. PubMed ID: 19205281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
    Compalati E; Passalacqua G; Bonini M; Canonica GW
    Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allergen-specific immune therapy in the treatment of asthma].
    Malling HJ
    Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.
    Penagos M; Compalati E; Tarantini F; Baena-Cagnani R; Huerta J; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):141-8. PubMed ID: 16937742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
    Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
    Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing and efficacy in specific immunotherapy.
    Demoly P; Calderon MA
    Allergy; 2011 Jul; 66 Suppl 95():38-40. PubMed ID: 21668851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials.
    Tao L; Shi B; Shi G; Wan H
    Clin Respir J; 2014 Apr; 8(2):192-205. PubMed ID: 24118881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evidence based overview of sublingual immunotherapy in children.
    Scala G; Di Rienzo Businco A; Ciccarelli A; Tripodi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):23-6. PubMed ID: 19944006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
    Mungan D; Misirligil Z; Gürbüz L
    Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.